why choose us

First received: September 19, 2023

Clinical Trial: A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Study Status: Completed

Recruit Status: RECRUITING

Condition: Solid Tumor, KRAS Mutation

Study Type: INTERVENTIONAL


Official Title: Open-label Dose-finding Trial to Explore Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 3706674 Given Orally as Monotherapy in Patients With Unresectable Metastatic KRAS Wild Type Ampl

Brief Summary: This study is open to adults with advanced cancer in the stomach and oesophagus.This is a study for people for whom previous treatment was not successful or no treatment exists.In this study, BI 3706674 is given to humans for the first time.The purpose of this study is to find a suitable dose of BI 3706674 that people with advanced cancer can tolerate when taken alone.Another purpose is to check whether BI 3706674 can make tumours shrink.BI 3706674 blocks growth signals and may prevent the tumour from…

Read more